ZeNix trial shows effectiveness of BPaL regimen for TB can be maintained with reduced dosing of…
The results from the trial, which was led by TB Alliance, were published in the 'New England Journal of Medicine'
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
TB Alliance
TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid
Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories, including many…
Trial reveals BPaL regimen for highly drug-resistant TB is effective even with reduced dose of…
This regimen reduces the treatment time for highly drug-resistant forms of TB from 18 months or longer to a six-month duration
TB Alliance and Macleods partners for new therapy for highly drug-resistant TB
Non-profit product development partnership and generic manufacturer agree to produce new TB drug for countries with high incidence…